Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world and is focused on building the future of healthcare and conducting research that turns into earlier diagnoses and new cures. At Mayo Clinic, experts work together to solve the most challenging unmet needs of patients and an unwavering drive to create better medical care has earned Mayo Clinic more top rankings for high-quality patient care than any other health care organization. Discovery Oasis, a biotechnology innovation hub located adjacent to the Mayo Clinic Phoenix Hospital, will create a vast ecosystem of biomanufacturing and health technology organizations within intersecting neighborhoods and amenities that encourage collaboration and convergence. At the heart of the Discovery Oasis lies a commitment to pioneering medical advancements – diagnostics that anticipate diseases before they manifest, treatments that are precisely tailored to each individual’s genetic makeup, interventions that are informed by cutting-edge data analysis and artificial intelligence, and so much more. Discovery Oasis will help to redefine the boundaries of what is achievable in healthcare, be a place where the human spirit of innovation shines brightly, and create a world where healthcare transcends expectations.
Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center is an economic development and investment agency with a mission of supporting the growth and development of the life sciences in Massachusetts. Through public-private funding initiatives, the Massachusetts Life Sciences Center supports innovation, research and development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. As a quasi-public agency, Massachusetts Life Sciences Center also offers programs that fund innovation-driven economic and workforce development initiatives in Massachusetts. The Massachusetts Life Sciences Center’s mission is to serve as the “hub” of the Massachusetts life sciences ecosystem, encourage innovation through investments in good science and good business, strengthen and protect Massachusetts’ global leadership position in the life sciences, accelerate the commercialization of promising treatments, therapies, and cures that will improve patient care, and create jobs and drive economic and STEM workforce development. | The Massachusetts Life Sciences Center (MLSC) is an economic development and investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond. | With a mission like no other and a myriad of programs, the Massachusetts Life Sciences Center (MLSC) moves the needle to accelerate breakthroughs and opportunities for all. Our focus is not just a hub, but a Commonwealth, home to an ecosystem that we’re building together. Catalyzing innovation and collaboration for the STEM learner, the physician scientist, and the next generation of entrepreneurs, we’re helping the life sciences move farther, faster. Every day we are supporting people, partnerships, and patients globally.
Life Science Cluster Friuli Venezia Giulia – Polo Tecnologico Alto Adriatico
Friuli Venezia Giulia Life Science cluster aims to promote the dialogue and collaboration between bodies and institutions to encourage development and innovation in the Life Science sector. The realities participating in the cluster are numerous and include research institutes, healthcare companies, hospitalization institutions, third sector realities, universities, companies in the pharmaceutical-medical sector. MAIN SECTORS Innovative biomedical solutions and systems: integrated development of medical devices; Active & assisted living solutions and systems to support frailty; Solutions and systems for innovative therapies: integrated development of drugs and biopharmaceuticals (biotech) for personalized and sustainable medicine; Systems and solutions for health maintenance and care support: nutraceuticals, food supplements, functional foods, medical nutrition and functional cosmetics.
leap:up GmbH / biosaxony e.V.
leap:up GmbH (a partner of the German biotech association biosaxony) empowers founders, startups, and SMEs in the life sciences to take significant steps towards innovation, market entry, commercialization, and growth. Our vision: A sustainably healthier world. Our mission is to support scientists, companies and startups in the field of life sciences to transform their innovative ideas into scalable business models. Through our projects and world-class services, we help to bridge the gap between idea and realization. “leap:up” stands for bold leaps into the future of life sciences. As a life science enabler, we create optimal conditions for the realization of groundbreaking ideas. Our portfolio includes acceleration and development services for life science projects, regulatory support, training programs, and events through our in-house academy, as well as the provision of state-of-the-art co-working labs in Leipzig. We are actively expanding our international presence and service, including investor relations and funding opportunities. Our focus areas include diagnostics, cell and gene therapy, radiopharmacy, smart medical devices, robotics and AI, digital health, and phage therapy.
Lead Discovery Center
The Lead Discovery Center (LDC) is a drug discovery incubator for academic projects and has several strategic alliances established (e.g. with the Max-Planck Society and several industry partners). Our pipeline comprises small molecules and monoclonal antibodies (incl. ADCs) in a wide range of indications such as oncology, cardiovascular, neurology, infectious diseases, inflammation, immunology, pain, respiratory, ophthalmology, and many others. Our business model includes starting new companies, licensing and collaborations in any design. The status of our small molecule based projects when they are available for licensing is lead nomination (proof of concept in a relevant disease model). We have all relevant infrastructure established (e.g. HTS, biology, assay development, medicinal and computational chemistry, pharmacology, PoC studies) and are permanently seeking new project ideas from academia.
Klaster LifeScience Kraków Foundation
Klaster Life Science Kraków – Driving Innovation at the Intersection of Science, Business, and Healthcare The Klaster Life Science Kraków is a thriving, cross-sectoral ecosystem that connects over 200 science and business organisations across biotech, medtech, diagnostics, pharma, healthcare, research, and public administration. Coordinated by the Klaster LifeScience Kraków Foundation, it catalyses innovation, strategic collaboration, and international business development in the heart of Central Europe. Located in Małopolska, one of Poland’s most innovation-driven regions, the Network provides access to cutting-edge R&D, top academic institutions, EU-funded infrastructure, and a pool of highly skilled professionals. It is an ideal entry point for foreign partners and investors seeking scalable solutions, co-development opportunities, and regional market expansion. The Network actively supports internationalisation through matchmaking missions, project consortia, and access to public-private initiatives aligned with the European Union’s Smart Specialisation Strategy. Its members benefit from structured innovation support, access to funding, and connections to policymakers and key opinion leaders. Małopolska, recognised as a European entrepreneurial region, offers competitive operational costs, investment incentives, and a stable regulatory environment. Kraków’s position as a life science hub makes it a springboard for ventures targeting Central and Eastern Europe. Discover Klaster Life Science Kraków at BIO International Convention—partner with us and be part of Europe’s next frontier in life science innovation and investment. Life Science Open Space – Where Collaboration Fuels Innovation The Life Science Open Space is the flagship collaboration platform of the Life Science Kraków Cluster—a unique event and year-round program dedicated to turning ideas into impactful solutions in health, quality of life, and sustainable development. Hosted annually in Kraków, Poland, and supported by a vibrant ecosystem of innovators, the platform connects a broad spectrum of stakeholders—from science, business, medicine, and public sectors—who share a common goal: to collaborate, not compete. At its core, Life Science Open Space (www.LSOS.info) redefines the traditional conference format. It is not a marketplace of products or services but a space for co-creation—where challenges are openly shared, projects are formed, and partnerships are forged. Through collaboration proposals, participants are invited to engage in meaningful conversations, contribute their expertise, and jointly develop solutions. LSOS offers a carefully curated program of thematic sessions, co-creation presentations, expert panels, and matchmaking opportunities. Its open formula encourages honest dialogue and transparency, empowering attendees to build multi-disciplinary project teams, apply for joint funding, and scale innovations faster. Whether you’re a researcher seeking industrial partners, a startup looking for clinical validation, or a corporation scouting disruptive tech, LSOS provides the right environment to accelerate ideas into action. The platform also serves as a gateway to long-term community engagement through its online extension (www.lifescienceopenspace.com), which fosters year-round collaboration. It supports ecosystem growth by linking innovation seekers with solution providers across Poland and Europe. By participating in Life Science Open Space, you gain more than contacts—you gain co-creators, champions, and access to a trusted network that values openness, trust, and shared impact. Visit www.lsos.info and www.lifescienceopenspace.com to discover how collaboration becomes a strategy in the Life Science Kraków cluster.
Kentucky Cabinet for Economic Development
Kentucky Cabinet for Economic Development creates a sustainable and active entrepreneurial ecosystem throughout the Commonwealth that is designed to identify, develop, retain and attract talented entrepreneurs utilizing an approach that focuses on inclusivity, connectivity, positivity, and a “give first” culture. KY Innovation, within the KY Cabinet for Economic Development, administers Kentucky’s SBIR/STTR Matching Funds Program. | As the primary state agency encouraging job creation, retention and business investment in Kentucky, the Cabinet for Economic Development works to attract new industries and assists existing companies to grow and expand. The Cabinet also provides support and resources for entrepreneurs, startups and small business owners. As well, it helps prepare communities for economic development opportunities. In addition to the Cabinet’s central office in Frankfort, KY, the Cabinet maintains international offices in Europe and Asia.
Jeonnam Bio Foundation
The Jeonnam Bio Foundation(jBF) is a prominent entity in Korea, noted for its high productivity and competitiveness within the bioindustry sector. The jBF is engaged in a variety of activities aimed at enhancing the bioindustry, including the development of functional foods, vaccines, pharmaceuticals, natural products, and products for medicine and cosmetics. They leverage Jeollanamdo’s rich natural resources for these developments, positioning bio-industries as strategic future industries for the region. Jeollanamdo is also recognized for its significant contribution to agriculture and fisheries, producing 19% of domestic agricultural products and 43% of domestic fishery products in Korea. The region is a leader in eco-friendly agricultural production, with 60% of its agricultural land using no pesticides, which underscores its commitment to sustainable and environmentally friendly practices. Furthermore, the Jeonnam Bio Foundation supports vaccine and pharmaceutical start-ups in collaboration with local institutions, such as the Hwasun Vaccine Industry Special District and Chonnam National University Hwasun Hospital, showcasing a strong emphasis on research and development (R&D) and innovation within the bioindustry sector. | Jeonnam Bio Foundation (JBF) *Organization Overview The Jeonnam Bio Foundation (JBF) is a public institution established by the Jeollanam-do Provincial Government to serve as a cornerstone for the growth and innovation of South Korea’s bioindustry. Strategically located within Jeonnam’s specialized bio-clusters, JBF plays a vital role in fostering industrial development, promoting technology commercialization, and supporting global market entry for biotechnology-driven enterprises. *Mission and Vision JBF is dedicated to creating a dynamic ecosystem for the bioindustry by connecting research with commercialization, supporting startups and SMEs, and advancing regional and global collaboration. The foundation envisions establishing Jeonnam as a global leader in sustainable and innovative biotechnology. * Core Functions 1) Enterprise Support – Business incubation and consulting for bioindustry startups and small to medium enterprises – Operation and rental of pilot production facilities and lab infrastructure – Regulatory and certification support (HACCP, GMP, ISO, etc.) 2) Technology Transfer & Commercialization – Promotion of joint R&D and transfer of technologies from academic and public institutions to industry – IP management and licensing services – Bridging academia and industry through innovation pipelines 3) Global Market Expansion – Assistance with international exhibitions, overseas buyer matching, and export consulting – Support for product registration and certification in global markets – Development of global partnerships and technology licensing agreements 4) Human Resource Development – Technical training and workforce development programs in bioprocessing and quality systems – Academic collaboration with universities and research institutions – Industry-focused job training and professional education *Strategic Role Located in Jeonnam’s national bioindustrial complexes, JBF offers integrated support combining research, testing, production, and commercialization. This strategic positioning makes JBF a crucial platform for domestic and global companies seeking to scale their bio-related technologies. *Notable Achievements – Successful incubation of numerous regional bioenterprises – Technology transfer and licensing to commercial partners – Hosting of international conferences and trade delegation events – Recognition for excellence in regional economic development and innovation
IZB – Innovation and Start-up Center Biotechnology
Hotspot for Life Sciences The Innovation and Start-up Center Biotechnology (IZB) with sites in Planegg-Martinsried and Freising-Weihenstephan near Munich, is one of the leading biotechnology centers in Europe. The company Fördergesellschaft IZB mbH, founded in 1995, operates IZB. IZB hosts over 40 biotech companies with more than 700 employees across a 26,000 m² area. At the main site in Planegg-Martinsried, spanning 23,000 m², resident start-ups primarily focus on medical biotechnology. IZB in Freising provides ideal conditions for founders in the life sciences sector. Outstanding infrastructure IZB offers young companies a superior environment and infrastructure for realizing their product and service ideas. Crucial for successful growth are S1 laboratories and office spaces that flexibly adapt to the companies‘ needs. Additionally, IZB provides excellent infrastructure. At the Martinsried location, start-ups have access to modern conference rooms, a design hotel, the restaurants „The Bowl“ and „Seven and More“, as well as the Bio Kids kindergarten. A strong network A vital success factor for IZB start-ups is the close proximity of both locations to cutting-edge research. On the Weihenstephan Campus, you’ll find the TUM school of Life Sciences of the Technical University of Munich, as well as the University of Applied Sciences Weihenstephan-Triesdorf. Adjacent to the IZB on the Martinsried/Großhadern campus, you‘ll find, among others, two Max Planck Institutes, faculties, and facilities of LMU, as well as the University Hospital of Munich-Großhadern. IZB fosters this strong network with an array of event formats like the IZBrunch and the Munich Life Science Pitch Day at the G2B Faculty Club, establishing itself as a key meeting point in the industry.